The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis
Vm. Corrigall et al., The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis, J IMMUNOL, 166(3), 2001, pp. 1492-1498
Rheumatoid arthritis (RA) is the most common, crippling human autoimmune di
sease. Using Western blotting and tandem mass spectroscopy, we have identif
ied the endoplasmic reticulum chaperone BiP, a 78-kDa glucose-regulated pro
tein, as a possible autoantigen, It preferentially stimulated increased pro
liferation of synovial T cells from patients with RA but not from patients
with other arthritides. Mice with established collagen- or pristane-induced
arthritis developed IgG Abs to BiP. Although BiP injected in CFA failed to
induce arthritis in several strains of rats and mice, including HLA-DR4(+/
-) and HLA-DR1(+/+)-transgenic animals, it completely inhibited the develop
ment of arthritis when given i.v. 1 wk before the injection of type II coll
agen arthritis. Preimmunization with BiP suppressed the development of adju
vant arthritis in Lewis rats in a similar manner. This is the first report
of a mammalian chaperone that is an autoantigen in human RA and in experime
ntal arthritis and that can also prevent the induction of experimental arth
ritis. These findings may stimulate the development of new immunotherapies
for the treatment of RA.